ArticleVaccines2024

Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1-2 Clinical Trial.

Gilda Lemos-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.